Matthew Kandrach – President, CASE April 20, 2020 Driven by opposition to fossil fuels, some environmental groups want a […]
Gerard Scimeca – Chairman, CASE April 17, 2020 As the coronavirus pandemic lays siege to everyday life, mobile technology […]
April 16, 2020 On January 21, 2020, the Centers for Disease Control and Prevention (CDC) confirmed the first case […]
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have […]
Gerard Scimeca – Chairman, CASE April 13, 2020 We are now past Day 100 since the arrival of the Covid-19 […]
Gerard Scimeca – Chairman, CASE April 10, 2020 Washington acted swiftly in passing the $2.2 trillion economic relief package to help […]
Matthew Kandrach – President, CASE April 10, 2020 In the COVID-19 era, the most mundane of activities—like going to the […]
Matthew Kandrach – President, CASE April 9, 2020 Here’s something all Americans should agree on: the United States should […]
March 20, 2020 Just as America has met every challenge we have faced throughout our history, there is little doubt […]
March 18, 2020 Prior to the interruptions caused due to the coronavirus, the Trump economy was surging. One of […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/